Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
CETROTIDE Drug Profile
« Back to Dashboard
This drug has twenty-five patent family members in twenty-two countries.
The generic ingredient in CETROTIDE is cetrorelix. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cetrorelix profile page.
Summary for Tradename: CETROTIDE
| Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: see list | 1 |
| Drug Prices: : | see details |
Clinical Trials for: CETROTIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | RX | Yes | 6,319,192 | Apr 23, 2019 | ||||||||||||||||||||
Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | DISCN | No | 6,319,192 | Apr 23, 2019 | ||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Patents for Tradename: CETROTIDE
These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | 4,800,191 | <disabled> | ||||||||||||||||||||||
Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | 7,605,121 | <disabled> | ||||||||||||||||||||||
Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-002 | Aug 11, 2000 | 6,863,891 | <disabled> | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
International Patent Family for Tradename: CETROTIDE
| Country | Document Number | Estimated Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | 2330131 | <disabled in preview> | |||||||||||||||||||||||||||
| Poland | 195989 | <disabled in preview> | |||||||||||||||||||||||||||
| Australia | 3702899 | <disabled in preview> | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
Supplementary Protection Certificates for Tradename: CETROTIDE
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9C0031 | Belgium | <disabled> | PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413 | ||||||||||||||||||||||||||
| 90029 | Netherlands | <disabled> | PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413 | ||||||||||||||||||||||||||
| /1999 | Austria | <disabled> | PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413 | ||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
To get information on drug patent expirations for the UK
— Commercial analyst, UK
To be informed abut patent protection and patent challenges
— Business development / Licensing / Marketing & sales, Italy
To know which brands are on and off patent
— Advertising sales pharma companies, USA
To obtain active pharmaceutical ingredient and pharmaceutical ingredient patents
— Marketing agency, UK
For information on when certain branded drugs expire, and where
— Director of procurement for clinical trials, USA
For competitive information on the pharmaceutical industry
— Business intelligence, USA
For knowledge about patent expiration dates and ongoing patent challenges
— Generic pharma, Canada
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
